According to the current posting on the website of the World Health Organization, the worldwide prevalence of diabetes mellitus among persons 18 years of age or older is 8.5% and increasing. Most of those affected have type 2 diabetes, which has been epidemic for several decades and is associated with many complications, including premature macrovascular and microvascular diseases affecting the eyes, heart, kidneys, and the circulation. We know that diabetes is associated with major morbidity and mortality, with an estimated 1.5 million deaths in 2012 being directly due to diabetes.1Various approaches in the treatment of type 2 diabetes have . . .